Annual EBIT
-$32.49 M
-$18.59 M-133.78%
December 31, 2023
Summary
- As of February 8, 2025, FBRX annual earnings before interest & taxes is -$32.49 million, with the most recent change of -$18.59 million (-133.78%) on December 31, 2023.
- During the last 3 years, FBRX annual EBIT has fallen by -$18.26 million (-128.37%).
- FBRX annual EBIT is now -133.78% below its all-time high of -$13.90 million, reached on December 31, 2022.
Performance
FBRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$8.63 M
+$4.19 M+32.68%
September 30, 2024
Summary
- As of February 8, 2025, FBRX quarterly earnings before interest & taxes is -$8.63 million, with the most recent change of +$4.19 million (+32.68%) on September 30, 2024.
- Over the past year, FBRX quarterly EBIT has dropped by -$2.25 million (-35.23%).
- FBRX quarterly EBIT is now -1271.86% below its all-time high of -$629.00 thousand, reached on June 30, 2019.
Performance
FBRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$35.63 M
+$1.59 M+4.26%
September 30, 2024
Summary
- As of February 8, 2025, FBRX TTM earnings before interest & taxes is -$35.63 million, with the most recent change of +$1.59 million (+4.26%) on September 30, 2024.
- Over the past year, FBRX TTM EBIT has dropped by -$3.15 million (-9.68%).
- FBRX TTM EBIT is now -5564.86% below its all-time high of -$629.00 thousand, reached on June 30, 2019.
Performance
FBRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
FBRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -133.8% | -35.2% | -9.7% |
| 3 y3 years | -128.4% | -35.2% | -9.7% |
| 5 y5 years | - | -35.2% | -9.7% |
FBRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -133.8% | at low | -243.2% | +32.7% | -190.7% | +4.3% |
| 5 y | 5-year | -133.8% | at low | -1161.5% | +32.7% | -2613.8% | +4.3% |
| alltime | all time | -133.8% | at low | -1271.9% | +32.7% | -5564.9% | +4.3% |
Forte Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.63 M(-32.7%) | -$35.63 M(-4.3%) |
| Jun 2024 | - | -$12.82 M(+64.2%) | -$37.22 M(+11.3%) |
| Mar 2024 | - | -$7.80 M(+22.3%) | -$33.44 M(+2.9%) |
| Dec 2023 | -$32.49 M(+133.8%) | -$6.38 M(-37.5%) | -$32.49 M(+4.6%) |
| Sep 2023 | - | -$10.22 M(+13.1%) | -$31.04 M(+28.0%) |
| Jun 2023 | - | -$9.03 M(+31.8%) | -$24.25 M(+33.0%) |
| Mar 2023 | - | -$6.86 M(+38.8%) | -$18.24 M(+31.2%) |
| Dec 2022 | -$13.90 M | -$4.94 M(+44.3%) | -$13.90 M(+13.4%) |
| Sep 2022 | - | -$3.42 M(+13.3%) | -$12.26 M(-25.9%) |
| Jun 2022 | - | -$3.02 M(+20.1%) | -$16.53 M(-14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.51 M(-23.8%) | -$19.26 M(-10.4%) |
| Dec 2021 | -$21.49 M(+51.0%) | -$3.30 M(-57.2%) | -$21.49 M(-5.3%) |
| Sep 2021 | - | -$7.70 M(+34.0%) | -$22.68 M(+13.5%) |
| Jun 2021 | - | -$5.75 M(+21.2%) | -$19.99 M(+18.0%) |
| Mar 2021 | - | -$4.74 M(+5.5%) | -$16.94 M(+19.1%) |
| Dec 2020 | -$14.22 M | -$4.49 M(-10.3%) | -$14.22 M(+46.2%) |
| Sep 2020 | - | -$5.01 M(+85.7%) | -$9.73 M(+80.0%) |
| Jun 2020 | - | -$2.70 M(+33.1%) | -$5.41 M(+61.9%) |
| Mar 2020 | - | -$2.03 M(+196.3%) | -$3.34 M(+154.4%) |
| Sep 2019 | - | -$684.00 K(+8.7%) | -$1.31 M(+108.7%) |
| Jun 2019 | - | -$629.00 K | -$629.00 K |
FAQ
- What is Forte Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Forte Biosciences?
- What is Forte Biosciences annual EBIT year-on-year change?
- What is Forte Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Forte Biosciences?
- What is Forte Biosciences quarterly EBIT year-on-year change?
- What is Forte Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Forte Biosciences?
- What is Forte Biosciences TTM EBIT year-on-year change?
What is Forte Biosciences annual earnings before interest & taxes?
The current annual EBIT of FBRX is -$32.49 M
What is the all time high annual EBIT for Forte Biosciences?
Forte Biosciences all-time high annual earnings before interest & taxes is -$13.90 M
What is Forte Biosciences annual EBIT year-on-year change?
Over the past year, FBRX annual earnings before interest & taxes has changed by -$18.59 M (-133.78%)
What is Forte Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of FBRX is -$8.63 M
What is the all time high quarterly EBIT for Forte Biosciences?
Forte Biosciences all-time high quarterly earnings before interest & taxes is -$629.00 K
What is Forte Biosciences quarterly EBIT year-on-year change?
Over the past year, FBRX quarterly earnings before interest & taxes has changed by -$2.25 M (-35.23%)
What is Forte Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of FBRX is -$35.63 M
What is the all time high TTM EBIT for Forte Biosciences?
Forte Biosciences all-time high TTM earnings before interest & taxes is -$629.00 K
What is Forte Biosciences TTM EBIT year-on-year change?
Over the past year, FBRX TTM earnings before interest & taxes has changed by -$3.15 M (-9.68%)